膜增殖性肾小球肾炎

  • 网络Membranoproliferative glomerulonephritis;MPGN;MePGN
膜增殖性肾小球肾炎膜增殖性肾小球肾炎
  1. 10例肾活检结果为局灶节段性肾小球硬化4例、硬化性肾小球肾炎3例、膜增殖性肾小球肾炎2例、IgA肾炎1例,其Scr低于平均水平(P<0.05)。

    In 10 kidney pathogen reports : there are 4 cases of focal segmental glomerulosclerosis , 3 cases of sclerosis nephritis , 2 cases of membranoproliferative glomerulonephritis , 1 case of IgA nephritis , and its level of serum Cr is lower than the average .

  2. 51例原发性膜增殖性肾小球肾炎的临床病理特征及预后

    Clinicopathology and Prognosis of 51 Idiopathic Membranoproliferative Glomerulonephritis Patients

  3. 血管病变在IgA肾病、系膜增殖性肾小球肾炎及膜性肾病中的比较

    Comparison of intrarenal artery lesions in patients with IgA nephropathy , mesangial proliferative glomerulonephritis and membranous nephropathy

  4. 目的:了解血管病变在IgA肾病(IgAN)与系膜增殖性肾小球肾炎(MsPGN)及膜性肾病(MN)中的不同特点。

    Objective : To analyze and compare the characteristics of intrarenal artery lesions in IgA nephropathy ( IgAN ), mesangial proliferative glomerulonephritis without IgA deposits ( MsPGN ) and membranous nephropathy ( MN ) .

  5. 观察分析口服CsA治疗26例小儿难治性肾病综合征(系膜增殖性肾小球肾炎15例、微小病变8例、系膜增殖并局灶性硬化2例)的疗效。

    The authors reported that 26 cases of children with refractory nephrotic syndrome were treated with cyclosporin A , which included 15 cases of MsPGN , 8 cases of MCNS , and 2 case of MsPGN with focal sclerosis .

  6. 目的:探讨内皮素(ET)对人肾小球基质金属蛋白酶-3(MMP-3)及其组织抑制剂-1(TIMP-1)表达的影响及其在慢性系膜增殖性肾小球肾炎进展中的作用。

    Objective : To investigate the effects of endothelin ( ET ) on the expressions of matrix metalloproteinase-3 ( MMP-3 ) and tissue inhibitor of metalloproteinase-1 ( TIMP-1 ) in glomerulus and its relationship with the progression of chronic glomerulonephritis .

  7. 结论芪加合剂对系膜增殖性肾小球肾炎模型的治疗机制可能与纠正MesPGN模型脂代谢异常有关。

    [ Conclusion ] The mechanisms of Qi Jia Mixture in treating MesPGN may be related to correction of abnormal lipid-metabolism .

  8. 膜增殖性肾小球肾炎的超微结构在病理学分型、诊断和鉴别诊断中的意义

    Significance of infrastructure of Membranoproliferative Glomerulonephritis in Pathological and Differential Diagnosis

  9. 骨碎补类黄酮对系膜增殖性肾小球肾炎大鼠模型的抑制作用

    Suppressive Effects of Flavonoid of Drynaria Fortunei on Mesangioproliferative Glomerulonephritis in Rats

  10. 儿童系膜增殖性肾小球肾炎临床与病理关系的研究

    The relationship between the clinics and pathology of mesangial proliferative glomerulonephritis in children

  11. 低分子肝素治疗大鼠系膜增殖性肾小球肾炎

    Low molecular heparin treated rat in mesangioproliferative glomerular nephritis

  12. 系膜增殖性肾小球肾炎血脂和载脂蛋白水平的变化及临床意义

    Changes and clinical significance of the level of blood lipid and apolipoprotein in mesangial proliferative glomerulonephritis

  13. 人类系膜增殖性肾小球肾炎中α-平滑肌肌动蛋白表达与肾脏细胞表型转化相关

    Expression of α - SM-Actin Correlates with Phenotypic Change of Renal cells in Human Mesangial Proliferative Glomerulonephritis

  14. 结论确诊患儿为部分脂肪营养不良合并膜增殖性肾小球肾炎(I型)。

    Conclusion The diagnosis of partial lipodystrophy associated with mesangiocapillary glomerulonephritis of the dense deposit type was established .

  15. 目的观察低分子肝素对系膜增殖性肾小球肾炎的治疗作用。

    Objective In order to investigate the effect of low molecular heparin on rats in mesangioproliferative glomerular nephritis .